Biology is on its way to drive manufacturing in the 21st century. The fields of life science, such as synthetic biology, genome engineering, regenerative medicine, etc., provide innovative sources for this frontier technology. An increasing number of investors are shifting their focus to the field of synthetic biology, and a large number of related companies have recently emerged. Predicted by Global Market Insights, the synthetic biology market is projected to reach $50 billion by 2025 from $11 billion in 2018, at a CAGR of 24%.

From 2010 to 2020, synthetic biology developed rapidly. The cost reduction of gene synthesis methods is mainly due to the introduction of new methods for printing thousands of oligonucleotides in parallel on chips to make “oligo pools”. Researchers can use CRISPR technology to perform gene editing and gene regulation. High-power calculations also open up new areas of modeling and prediction. Advances in science and technology have solved a series of research problems and improved the way people work. Synthetic biology technology has also changed from an emerging discipline to a developing discipline.

Synthetic Biology Services | Synbio Technologies

Synbio Technologies established a proprietary bio-design, bio-synthesis, and bio-learning platform to provide a broad range of DBTL steps (Design-Build-Test-Learn) in the synthetic biology pipeline. Our synthetic biology services cover pathway design, DNA synthesis, strain construction, enzyme engineering, metabolites analysis, bioprocess development, and more. Our Ph.D. level scientists help you with consultation, evaluation, and execution of your interests in all DBTL service areas.